ofa tirzepatide lawsuit Eli Lilly sues companies selling alternative versions of its weight loss drug Compounder in Lilly lawsuit hit
Description
Tirzepatide and semaglutide have both been studied in pivotal trials for weight loss
The lawsuit targets what Lilly considers unauthorized manufacturing and deceptive marketing practices
Some people experience temporary digestive changes as their system readjusts
Hair loss
Batch-to-batch variation within the same pharmacy Even from the same pharmacy, consecutive vials might show slight color differences
Some researchers find larger volumes uncomfortable, and the storage duration becomes a consideration since you are pulling more liquid from the vial each week
